Skip to main content
Equibles

HRT FINANCIAL LP

Position in DMRA — Damora Therapeutics, Inc.

CIK 1475597 NEW YORK, NY
Back to DMRA Full portfolio

Position in DMRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$484,774
-$1,382,952 QoQ
Shares Held
18,638
-74.2% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 104 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DMRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. DMRA ranks #78 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,089,376 $81,136,724
2 INSM
INSMED Inc
 689,981 $73,565,774
3 EXEL
Exelixis, Inc.
 929,242 $50,560,057
4 MDGL
Madrigal Pharmaceuticals, Inc.
 84,634 $45,444,226
5 AXSM
Axsome Therapeutics, Inc.
 178,491 $43,689,242
6 ARWR
Arrowhead Pharmaceuticals, Inc.
 498,655 $40,645,369
7 ABVX
Abivax S.A.
 270,612 $36,061,755
8 TGTX
Tg Therapeutics, Inc.
 622,603 $34,205,808

All Filings in DMRA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $484,774 18,638
2026-03-31 $1,867,726 72,113